Search Results for "Vaccine Company In Pune"

18:06 EDT 23rd October 2016 | BioPortfolio

Matching Channels

Matching News

Immunovaccine Announces Positive Phase 1 Topline Data for DepoVax-based Respiratory Syncytial Virus Vaccine Candidate / Safety and Immunogenicity Results Highlight Advantages of Company's Proprietary RSV Antigen Target - - 15 of 16 Patients in DP

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 10/13/16 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy company, today annou...

Researchers to Present Data on Immunovaccine's Infectious Disease Pipeline at Three International Conferences / Presentations at RSV16, World Vaccine Congress Europe and IDWeek Conferences Highlight Company's Progress in Using DepoVax-based Agents to

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 09/23/16 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical-stage vaccine and immunotherapy company, today annou...

Merck joins DiViNe consortium to improve vaccine purification processes

Company to provide chromatographic expertise to 5-year project, which aims to create a more cost-effective vaccine purification programme

Takeda Initiates World’s First Norovirus Vaccine Field Trial

NewsTakeda Pharmaceutical Company Limited announced that it has dosed the first subject in a Phase 2b field efficacy trial of Takeda’s norovirus vaccine candidate, the only norovirus vaccine candid...

Takeda Initiates World's First Norovirus Vaccine Field Trial

Osaka, Japan, June 20, 2016 – Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has dosed the first subject in a Phase 2b field efficacy trial of ...

First Response to Zika Replikins Vaccine Candidates Reported

TORONTO, May 5, 2016 /PRNewswire/ -- Replikins Ltd. today reported initial promising results in animal trials of its Zika vaccine candidates. Logo -

Gaps in Vaccine Coverage Highlighted by New Report and Online Tool

As the 69th World Health Assembly discusses progress on the Global Vaccine Action Plan, a new data visualization platform from the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloom...

The HPV Vaccine: Then and Now

The short history of the HPV vaccine has been eventful. Will the first vaccine to prevent cancer survive this rocky patch? Medscape Family Medicine

Matching PubMed Articles

Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.

Factors, such as age, comorbidities, vaccine type, herd immunity, previous influenza exposure, and antigenic shift, may impact the immune response to the influenza vaccine, protection against circulat...

Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan.

As of 2014, routine vaccination strategies in Japan have included the varicella vaccine. Given the widespread use of the vaccine, it is important to investigate the safety profile of the vaccine strai...

Modeling HIV vaccine trials of the future.

Models of implementation of known-effective interventions for HIV prevention indicate that an efficacious vaccine to prevent HIV infection would be critical for controlling the HIV pandemic. Key issue...

A Dengue Vaccine.

Denvaxia is the first licensed vaccine for the prevention of dengue. It is a live vaccine developed using recombinant DNA technology. The vaccine is given as three doses over the course of a year and ...

HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland.

Background Men who have sex with men (MSM), particularly HIV-infected MSM are disproportionately affected by HPV infection and associated disease. The HPV vaccine has potential to greatly reduce the b...

Search Whole site using Google

Quick Search
Advertisement Advertisement